Biofrontera Group

Biofrontera group email format

Verified email-pattern data for Biofrontera Group is currently limited. You can still use the company insights and contact sections below.
Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics. The Germany-based company develops and markets innovative products for the care, protection and treatment of the skin. The company’s lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In the EU, the company also sells the dermocosmetics series Belixos®, which offers specialized care for damaged or diseased skin. Biofrontera is the first German pharmaceutical company to receive a centralized European and a US approval for a drug developed in-house. The Biofrontera Group was founded in 1997 and is listed on the Frankfurt Stock Exchange (ticker symbol: B8F) and on the US NASDAQ (ticker symbol: BFRA).

Company Details

Employees
95
Founded
-
Address
Hemmelrather Weg 201, Leverkusen,nordrhein-Westfalen 51377,germany
Industry
Pharmaceutical Manufacturing
HQ
Leverkusen, Nordrhein-Westfalen
Looking for a particular Biofrontera Group employee's phone or email?

Biofrontera Group Questions

Top Biofrontera Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant